Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Reducing phantom limb pain in amputees

Official title: TITAN: a Randomised Controlled Trial Investigating the Effectiveness of Two Treatment Programs for Reducing Phantom Limb Pain Intensity and Its Interference with Function

Run by Neuroscience Research Australia · NCT06167330 · Data updated 2026-11-12

This study is testing two different rehabilitation programs to see which one helps amputees with phantom limb pain feel better.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment208 (estimated)
SponsorNeuroscience Research Australia
Academic / other
Locations1 site (Randwick, New South Wales)
StatusRecruiting
StartedDecember 18, 2023
Main results expectedDecember 18, 2026
Study endsDecember 18, 2027
Registry record updatedDecember 5, 2024
Trial IDNCT06167330 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals who have undergone an amputation and have been experiencing phantom limb pain for at least three months.

Probably not a fit

Patients with bilateral amputations or those with cognitive impairments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effectiveness of two rehabilitation programs for individuals with amputations experiencing phantom limb pain. Participants will be randomized into two groups: one receiving a progressive rehabilitation program that includes pain science education, sensory training, and mirror therapy, and the other receiving treatment with transcutaneous electrical nerve stimulation and cranial electrical stimulation. The study aims to determine which approach is more effective in reducing pain intensity and interference. A total of 208 participants will be involved in this research.

Why it matters

Potential benefit: If successful, this study could significantly reduce phantom limb pain for amputees, improving their quality of life.

How similar studies have gone: Other studies have shown varying degrees of success with rehabilitation and stimulation approaches for phantom limb pain, but this specific comparison is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Experiencing phantom limb pain for at least three months.
* Report at least one episode of phantom limb pain in the previous week.
* Report at least 4 points in pain intensity over the previous 7 days, assessed using the 11-point Numerical Pain Rating Scale.
* Be a resident in Australia for the intervention and follow-up period.
* Have access to the internet and smart device (e.g., mobile phone).
* Be proficient in English.

Exclusion Criteria:

* Bilateral amputation.
* Scheduled for major surgery during the study period.
* Pain in the intact limb.
* Vision impairment that would preclude successful participation.
* Auditory impairment that would preclude successful participation.
* Cognitive problems that would preclude effective participation in trial procedures (e.g., Alzheimer's, dementia).
* Previously diagnosed neurological disorders that affect the movement of the intact limb (e.g., stroke, Parkinson, Multiple Sclerosis).
* Completed Graded Motor Imagery in the order of left/right judgements, imagined movements, and mirror therapy.
* Have contraindications for the use of stimulation devices (e.g., pacemaker, spinal cord stimulator).

Where it's running

  • Neuroscience Research Australia
    Randwick, New South Wales, Australia
    Recruiting

Study contacts

  • Principal investigator: James H McAuley, PhD — Neuroscience Research Australia
  • Study coordinator: James H McAuley, PhD
  • Email: j.mcauley@neura.edu.au
  • Phone: +61293991266

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.